123 related articles for article (PubMed ID: 38349953)
1. Serum neurofilament light chain - A potential biomarker for polyneuropathy in type 2 diabetes?
Määttä LL; Andersen ST; Parkner T; Hviid CVB; Bjerg L; Kural MA; Charles M; Søndergaard E; Sandbæk A; Tankisi H; Witte DR; Jensen TS
Diabetes Res Clin Pract; 2023 Nov; 205():110988. PubMed ID: 38349953
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.
Määttä LL; Andersen ST; Parkner T; Hviid CVB; Bjerg L; Kural MA; Charles M; Søndergaard E; Kuhle J; Tankisi H; Witte DR; Jensen TS
Diabetes Care; 2024 Jun; 47(6):986-994. PubMed ID: 38502878
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Serum Neurofilament Light Chain and Nerve Ultrasound in Diabetic Neuropathy.
Nasr-Eldin YK; Cartwright MS; Hamed A; Ali LH; Abdel-Nasser AM
J Ultrasound Med; 2024 Apr; 43(4):683-696. PubMed ID: 38124499
[TBL] [Abstract][Full Text] [Related]
5. Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes.
Itani M; Gylfadottir SS; Krøigård T; Kristensen AG; Christensen DH; Karlsson P; Möller S; Andersen H; Tankisi H; Nielsen JS; Jensen TS; Thomsen RW; Finnerup NB; Sindrup SH
J Peripher Nerv Syst; 2021 Mar; 26(1):55-65. PubMed ID: 33295647
[TBL] [Abstract][Full Text] [Related]
6. Higher Levels of Cerebrospinal Fluid and Plasma Neurofilament Light in Human Immunodeficiency Virus-Associated Distal Sensory Polyneuropathy.
Ellis RJ; Chenna A; Lie Y; Curanovic D; Winslow J; Tang B; Marra CM; Rubin LH; Clifford DB; McCutchan JA; Gelman BB; Robinson-Papp J; Petropoulos CJ; Letendre SL
Clin Infect Dis; 2023 Mar; 76(6):1103-1109. PubMed ID: 36310512
[TBL] [Abstract][Full Text] [Related]
7. PAPP-A activity is increased in cerebrospinal fluid from patients with diabetic polyneuropathy and correlates with peripheral nerve impairment.
Kallestrup M; Frystyk J; Espelund U; Hjortebjerg R; Tankisi H; Andersen H
Growth Horm IGF Res; 2019; 48-49():53-59. PubMed ID: 31670029
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
[TBL] [Abstract][Full Text] [Related]
9. Corneal confocal microscopy as a tool for detecting diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes: ADDITION-Denmark.
Andersen ST; Grosen K; Tankisi H; Charles M; Andersen NT; Andersen H; Petropoulos IN; Malik RA; Jensen TS; Karlsson P
J Diabetes Complications; 2018 Dec; 32(12):1153-1159. PubMed ID: 30309785
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review.
Kodal LS; Witt AM; Pedersen BS; Aagaard MM; Dysgaard T
J Peripher Nerv Syst; 2024 Mar; 29(1):17-27. PubMed ID: 38066727
[TBL] [Abstract][Full Text] [Related]
11. Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review.
Berends M; Nienhuis HLA; Adams D; Karam C; Luigetti M; Polydefkis M; Reilly MM; Sekijima Y; Hazenberg BPC
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612579
[TBL] [Abstract][Full Text] [Related]
12. Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes.
Qiao X; Zhang S; Zhao W; Ye H; Yang Y; Zhang Z; Miao Q; Hu R; Li Y; Lu B
Medicine (Baltimore); 2015 Nov; 94(44):e1908. PubMed ID: 26554790
[TBL] [Abstract][Full Text] [Related]
13. Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults.
Thota RN; Chatterjee P; Pedrini S; Hone E; Ferguson JJA; Garg ML; Martins RN
Front Endocrinol (Lausanne); 2022; 13():915449. PubMed ID: 35795150
[TBL] [Abstract][Full Text] [Related]
14. Sciatic nerve fractional anisotropy and neurofilament light chain protein are related to sensorimotor deficit of the upper and lower limbs in patients with type 2 diabetes.
Kender Z; Jende JME; Kurz FT; Tsilingiris D; Schimpfle L; Sulaj A; von Rauchhaupt E; Bartl H; Mooshage C; Göpfert J; Nawroth P; Herzig S; Szendroedi J; Bendszus M; Kopf S
Front Endocrinol (Lausanne); 2023; 14():1046690. PubMed ID: 37008917
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma neurofilament light chain in immune-mediated neurological disorders (IMND) detected by immunomagnetic reduction (IMR).
Huang KY; Wu CL; Chang YS; Huang WY; Su FC; Lin SW; Chien YY; Weng WC; Wei YC
Brain Res; 2023 Dec; 1821():148587. PubMed ID: 37739331
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
[TBL] [Abstract][Full Text] [Related]
17. Machine learning analysis of the UK Biobank reveals prognostic and diagnostic immune biomarkers for polyneuropathy and neuropathic pain in diabetes.
Allwright M; Karrasch JF; O'Brien JA; Guennewig B; Austin PJ
Diabetes Res Clin Pract; 2023 Jul; 201():110725. PubMed ID: 37211253
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
19. Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients.
Fukami Y; Iijima M; Koike H; Yamada S; Hashizume A; Katsuno M
J Neurol; 2021 Oct; 268(10):3835-3844. PubMed ID: 33797627
[TBL] [Abstract][Full Text] [Related]
20. Plasma neurofilament light chain concentrations are elevated in youth-onset type 2 diabetes and associated with neuropathy.
Fridman V; Sillau S; Ritchie A; Bockhorst J; Coughlan C; Araya P; Espinosa JM; Smith K; Lange EM; Lange LA; Ghormli LE; Drews KL; Zeitler P; Reusch JEB
J Peripher Nerv Syst; 2023 Sep; 28(3):460-470. PubMed ID: 37341347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
